| Predicted Trait | |
| Reported Trait | Esophageal cancer |
| Mapped Trait(s) | esophageal carcinoma (EFO_0002916) |
| Score Construction | |
| PGS Name | PRS14_esophageal |
| Development Method | |
| Name | Genome-wide significant variants |
| Parameters | r2>=0.93 |
| Variants | |
| Original Genome Build | hg19 |
| Number of Variants | 14 |
| Effect Weight Type | NR |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000328 |
| Citation (link to publication) | Choi J et al. Int J Cancer (2020) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 21,271 individuals (100%) |
| PGS Evaluation | European: 100% 1 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST003739 Europe PMC: 27527254 |
21,271 individuals | European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM013027 | PSS009661| European Ancestry| 406 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Esophageal cancer | — | AUROC: 0.53 [0.51, 0.56] | — | — | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS009661 | esophageal cancer (ICD-9 = 150 or ICD-10 = C15) | — | 406 individuals | — | European | — | UKB | — |